Shandong Weigao Group Medical Polymer Company Limited (1066.HK)

Healthcare | Medical Instruments Supplies
Income Statement (Quarterly) 2026-04-08 2025-06-30 2025-03-31 2024-12-31
Revenue 6,644,048,000 6,644,048,000 3,322,024,000 3,225,691,500
Cost of Revenue 3,340,540,000 3,340,540,000 1,670,270,000 1,646,080,500
Gross Profit 3,303,508,000 3,303,508,000 1,651,754,000 1,579,611,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 1,812,231,000 1,812,231,000 906,115,500 912,890,500
Operating Expenses 2,127,763,000 2,127,763,000 1,063,881,500 1,074,700,500
Operating Income 1,175,745,000 1,175,745,000 587,872,500 504,910,500
Interest Expense 0 116,773,000 0 0
Income Before Tax 1,225,904,000 1,225,904,000 612,952,000 593,684,500
Income Tax Expense 168,919,000 168,919,000 84,459,500 89,111,500
Net Income 1,008,317,000 1,008,317,000 504,158,500 479,559,500
Per Share
EPS 0.22 0.22 0.11 0.10
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 13,087,071,000 13,229,453,000 13,619,007,000 13,151,719,000 11,345,252,000
Cost of Revenue 6,506,440,000 6,586,420,000 6,505,925,000 5,882,315,000 4,887,962,000
Gross Profit 6,580,631,000 6,643,033,000 7,113,082,000 7,269,404,000 6,457,290,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 3,628,787,000 3,832,220,000 3,543,766,000 3,773,472,000 3,657,329,000
Operating Expenses 4,194,457,000 4,345,928,000 3,965,620,000 4,152,392,000 3,966,993,000
Operating Income 2,386,174,000 2,180,397,000 3,561,415,000 3,117,012,000 2,490,297,000
Interest Expense 249,572,000 272,971,000 191,401,000 140,396,000 178,935,000
Income Before Tax 2,553,748,000 2,369,187,000 3,317,901,000 2,841,721,000 2,496,029,000
Income Tax Expense 391,032,000 307,585,000 424,267,000 415,093,000 345,638,000
Net Income 2,066,668,000 2,001,906,000 2,723,309,000 2,244,778,000 2,030,137,000
Per Share
EPS 0.46 0.44 0.60 0.50 0.45
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 7,780,310,000 6,988,731,000 6,862,278,000 6,628,927,000
Short Term Investments 541,498,000 344,582,000 495,337,000 429,752,000
Net Receivables 7,455,486,000 5,960,128,000 5,735,233,000 0
Inventory 2,528,425,000 2,495,352,000 2,315,343,000 1,734,557,000
Total Current Assets 19,442,540,000 18,634,291,000 18,090,392,000 16,113,346,000
Property Plant Equipment 7,084,117,000 7,006,731,000 7,313,003,000 6,663,417,000
Goodwill and Intangibles 5,135,409,000 5,064,970,000 5,360,917,000 5,147,074,000
Total Assets 34,759,849,000 33,670,231,000 33,195,926,000 30,367,058,000
Liabilities
Account Payables 4,294,068,000 4,319,784,000 1,809,704,000 1,733,440,000
Short Term Debt 1,241,799,000 2,573,337,000 990,131,000 624,316,000
Total Current Liabilities 6,080,504,000 7,582,041,000 5,934,523,000 5,112,975,000
Long Term Debt 2,951,347,000 1,595,980,000 3,501,266,000 3,513,094,000
Total Liabilities 9,418,283,000 9,677,526,000 9,749,323,000 9,459,608,000
Shareholders Equity
Retained Earnings 19,852,418,000 18,627,532,000 17,312,614,000 0
Total Shareholders Equity 23,751,643,000 22,449,121,000 21,668,937,000 19,267,091,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 7,780,310,000 6,988,731,000 6,862,278,000 6,628,927,000 5,514,331,000
Short Term Investments 541,498,000 344,582,000 495,337,000 429,752,000 469,610,000
Net Receivables 7,455,486,000 5,960,128,000 5,735,233,000 0 0
Inventory 2,528,425,000 2,495,352,000 2,315,343,000 1,734,557,000 1,504,126,000
Total Current Assets 19,442,540,000 18,634,291,000 18,090,392,000 16,113,346,000 14,125,215,000
Property Plant Equipment 7,084,117,000 7,006,731,000 7,313,003,000 6,663,417,000 6,069,713,000
Goodwill and Intangibles 5,135,409,000 5,064,970,000 5,360,917,000 5,147,074,000 5,155,401,000
Total Assets 34,759,849,000 33,670,231,000 33,195,926,000 30,367,058,000 27,344,669,000
Liabilities
Account Payables 4,294,068,000 4,319,784,000 1,809,704,000 1,733,440,000 1,837,959,000
Short Term Debt 1,241,799,000 2,573,337,000 990,131,000 624,316,000 306,473,000
Total Current Liabilities 6,080,504,000 7,582,041,000 5,934,523,000 5,112,975,000 4,499,416,000
Long Term Debt 2,951,347,000 1,595,980,000 3,501,266,000 3,513,094,000 4,014,525,000
Total Liabilities 9,418,283,000 9,677,526,000 9,749,323,000 9,459,608,000 8,954,215,000
Shareholders Equity
Retained Earnings 19,852,418,000 18,627,532,000 17,312,614,000 0 0
Total Shareholders Equity 23,751,643,000 22,449,121,000 21,668,937,000 19,267,091,000 18,390,454,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income 2,553,748,000 2,369,187,000 3,317,901,000 2,244,778,000
Depreciation & Amortization 971,796,000 911,704,000 802,512,000 723,813,000
Stock Based Compensation 36,020,000 55,459,000 91,767,000 76,492,000
Change in Working Capital -291,727,000 -315,232,000 -1,136,557,000 -204,934,000
Operating Cash Flow 2,789,971,000 2,798,529,000 2,214,574,000 3,035,163,000
Investing Activities
Capital Expenditure -596,714,000 -685,664,000 -1,116,239,000 -1,116,882,000
Investments -596,714,000 -647,577,000 -1,116,239,000 -1,070,684,000
Investing Cash Flow -1,104,415,000 -1,388,592,000 -2,568,963,000 -1,479,374,000
Financing Activities
Debt Repayment -102,002,000 -364,530,000 -874,672,000 -706,641,000
Common Stock Issued/Repurchased -30,434,000 -36,530,000 -70,496,000 188,461,000
Dividends Paid -870,588,000 -732,633,000 -741,638,000 -653,288,000
Financing Cash Flow -1,595,939,000 -2,157,858,000 -1,020,957,000 -538,080,000
Summary
Free Cash Flow 2,191,925,000 2,112,865,000 1,098,335,000 1,918,281,000
Net Change in Cash 145,421,000 -723,590,000 -1,279,186,000 963,271,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income 2,553,748,000 2,369,187,000 3,317,901,000 2,244,778,000 2,030,137,000
Depreciation & Amortization 971,796,000 911,704,000 802,512,000 723,813,000 690,694,000
Stock Based Compensation 36,020,000 55,459,000 91,767,000 76,492,000 30,662,000
Change in Working Capital -291,727,000 -315,232,000 -1,136,557,000 -204,934,000 -262,948,000
Operating Cash Flow 2,789,971,000 2,798,529,000 2,214,574,000 3,035,163,000 2,696,608,000
Investing Activities
Capital Expenditure -596,714,000 -685,664,000 -1,116,239,000 -1,116,882,000 -995,625,000
Investments -596,714,000 -647,577,000 -1,116,239,000 -1,070,684,000 -935,598,000
Investing Cash Flow -1,104,415,000 -1,388,592,000 -2,568,963,000 -1,479,374,000 423,221,000
Financing Activities
Debt Repayment -102,002,000 -364,530,000 -874,672,000 -706,641,000 -2,593,945,000
Common Stock Issued/Repurchased -30,434,000 -36,530,000 -70,496,000 188,461,000 258,763,000
Dividends Paid -870,588,000 -732,633,000 -741,638,000 -653,288,000 -701,349,000
Financing Cash Flow -1,595,939,000 -2,157,858,000 -1,020,957,000 -538,080,000 -1,793,841,000
Summary
Free Cash Flow 2,191,925,000 2,112,865,000 1,098,335,000 1,918,281,000 1,700,983,000
Net Change in Cash 145,421,000 -723,590,000 -1,279,186,000 963,271,000 0